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ENDOVASCULAR AND SURGICAL  TECHNIQUES 
The Effect of Endovascular Aortic Stents Placed Across the Renal 
Arteries 
M. Malina .1, M. Lindh 2, K. Ivancev 2, B. Frennby 2, B. Lindblad 1 and J. BrunkwalP 
Departments of1Vascular Surgery and 2Radiology, Malta6 University Hospital, Lund University, Malmi~, Sweden 
Objectives: To investigate r nal artery patency and renal function after deployment of aortic stents covering the orifices 
of renal arteries. 
Design: Prospective open animal study. 
Setting: Department ofExperimental Surgery at a university hospital. 
Materials: Twenty-three pigs were used. 
Methods: Ten pigs were observed for 1 halter graft-anchoring aortic stents, Gianturco (5) and Palmaz (5), were placed 
so that the stents covered the renal arterial orifices. In 13 pigs, Gianturco (6) and Palmaz (7) stents without grafts were 
placed over the renal arteries and left in situ for 7 days. Renal function and blood flow were measured by renograms, iohexol 
clearance and ultrasonic blood flow meter and patency was verified by angiograms. The kidneys were microscopically 
examined for signs of ischaemia and microemboli. 
Results: One renal artery covered by a graft-anchoring Gianturco stent occluded. The remaining renal arteries remained 
patent without any significant &crease in renal blood flow after stent deployment. Normal renal function and histology was 
maintained. 
Conclusions: Aortic stents placed at the level of the renal arteries do'not affect renal blood flow within 1 week in this 
experimental model. This may prove valuable in endovascular treatment ofaortic aneurysms and in other procedures 
involving stents. 
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Introduction 
The implantation of stents, both self expandable and 
balloon inflatable, has become a common tool in 
endovascular interventions. ~ Intra-arterial stents are 
known to induce smooth muscle cell migration with 
the risk of restenosis. In animal experiments he stents 
will be covered by endothelial cells within months and 
may eventually be totally incorporated into the arte- 
rial wal l .  5-12 
Exclusion of aortic aneurysms and bypassing of 
occlusive disease is feasible by endovascular tech- 
13-17 18 niques. • Different stent devices are being utilised 
to anchor the graft to the aortic wall. However, the 
non-dilated proximal part of the infrarenal aorta - -  
between the orifices of the renal arteries and the 
*Please address all correspondence to: Martin Malina, Department 
of Vascular Surger~ Malm6 University Hospital S-205 02 Malm6, 
Sweden. 
aneurysm - -  is often very short. It may then be 
impossible to safely anchor the stent o this "neck". If 
endovascular exclusion was attempted in these cases, 
the stent would have to be positioned more proxi- 
mally, thus interfering with the origins of the renal 
arteries. Major arterial sidebranches often occur in the 
vicinity of the site of the proximal stent also when 
attempting endovascular grafting for occlusive 
disease. 
There are reports that arterial side branches will stay 
patent for at least 36 months after their orifices have 
been covered by stents. 1°'19-2° These observations are 
based exclusively on angiographic findings concern- 
ing the internal iliac, inferior mesenteric and lumbar 
arteries. The renal arteries have only been scarcely 
investigated and functional evaluation such as actual 
flow measurements of the involved side-branches has 
not been reported upon. The objective of this experi- 
mental study was to investigate the effects of aortic 
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Table 1. Disposition of animals (n=23) involved in this study. 
Study n = 23 Stent 
Graft anchoring stent covering renal arteries; 5 Gianturco 
feasibility study, I h follow-up 5 Palmaz 
Blood flow in renal arteries, covered by stent; 6 Gianturco 
7 days follow-up 7 Palmaz 
stents, covering the origins of the renal arteries, on risk 
for arterial occlusion, on renal blood flow and renal 
function. Two different stents were investigated, the 
self expanding Gianturco stent and the balloon 
expandable Palmaz stent. Both types of stents are 
utilised in anchoring endovascular grafts. 
Materials and Methods 
This study comprised two series of experiments on 
pigs (Table 1). In the first series an evaluation of the 
immediate (1 h) effects of graft anchoring aortic stents 
on the renal arteries was carried out. In the second 
series stents alone were placed transfemorally over the 
renal arteries and followed for 1 week. Patency, 
intraoperative renal and aortic blood flow, iohexol 
clearance, renograms and creatinine levels were 
registered. 
Twenty-three Swedish land race pigs (mean weight 
32.5 kg, S.D. 2.9 kg) were anaesthetised with mid- 
azolam (Dormicum®, Roche, Basel, Switzerland), 
ketamin (Ketalar®, Parke-Davis, Morris Plains, 
U.S.A.) and nitrous oxide and mechanically venti- 
lated. During laparotomy, lasting approximately 2 h, 
the animals lost fluid mainly due to damage to the 
cisterna chyli which embraces the aorta. These losses 
were compensated by the intravenous administration 
of 1500 ml of saline (37°C) and 500 ml dextran 70 
(Macrodex®, Kabi Pharmacia, Uppsala, Sweden) 
while body temperature was maintained by keeping 
the pigs on a heated pad. During procedures limited 
to the groin, volume substitution consisted of dextran 
solely. Heparin (7500 IU) was added prior to arterial 
clamping to prevent hrombosis in the stent regions, 
but thereafter no additional pharmacologic treatment 
was given. 
Inc., Ithaca, U.S.A.) zl placed in contact with both the 
renal arteries and the aorta separately. Basic flow 
values were obtained before stent deposition in the 
first series of animals where a laparatomy had to be 
carried out to enable deposition of the endovascular 
graft. In order to correct for variation in cardiac 
output, renal blood flow was expressed as a percent- 
age of the infrarenal aortic blood flow. 
Graft-stent placement 
In 10 animals (Table 1) the aorta was clamped below 
the inferior mesenteric artery and a transverse aortot- 
omy was performed. An 8 mm knitted Dacron graft 
(Haemashield®, Meadox Medicals Inc. U.S.A.), with a 
proximal and a distal stent sutured to the graft was 
introduced through a 16 F introducer sheath and 
deployed into the infrarenal aorta. Gianturco (Cook 
Inc., Bloomington, U.S.A.) or Palmaz (P-294, Johnsson 
& Johnsson Interventional Systems Co, Warren, 
U.S.A.) stents were used in five animals each at 
random. The diameter of the expanded stents was 9 
mm and the pore diameter was 5 and 3 mm 
respectively. The proximal, 30 mm long stent was 
attached to the graft in such a way that half of the stent 
was uncovered (Fig. 1). The uncovered part of the 
stent was placed over the orifices of the renal arteries 
and its position was controlled by angiography. After 
suturing the aortotomy, blood flow was measured 
repeatedly and after i h patency of the aorta and renal 
arteries was also verified by another angiogram. At 
the end of the experiment the aorta was clamped and 
the graft containing specimen excised. The patency of 
the renal arteries was examined as well as the exact 
location of the stent and graft margins and their 
relation to the renal arteries. Occurrence of thrombi 
was particularly noted. The kidneys were histo- 
logically examined by pathologists as described 
below. In the second series, with 1 week follow-up, 
stents without grafts were studied. The stents, Gian- 
turco (6) and Palmaz (7), were introduced by a 
transfemoral approach into the aorta, and placed to 
cover the renal artery orifices. The position was 
verified by angiography. 
Blood flow 
Blood flow was measured by an ultrasonic probe (T 
101, Ultrasonic Blood Flow Meter, Transonic Systems 
Renal function 
Renal function was monitored by renograms and 
creatinine registrations, preoperatively and postoper- 
atively on day 2 and 7 in the Gianturco group. In the 
Eur J Vasc Endovasc Surg Vol 13, February 1997 
Stents Across Renal Arteries 209 
Palmaz group the renograms were replaced by regis- 
trations of iohexol clearance due to technical failure of 
the gamma camera. Using computerised renograms, 
the time to maximal isotope uptake (T-MAX) as well 
as the initial inclination of the curve (INCL) were 
calculated. Plasma-clearance of iohexol was deter- 
mined by the slope technique. 22'23 Plasma concentra- 
tion of iodine was obtained using the Renalyzer 
PRX90 (Provalid AB, Lund, Sweden) which is based 
on X-ray fluorescence t chnique. Plasma samples were 
taken 1, 2 and 3 h after the injection of 25 ml of iohexol 
300 mg iodine/ml (Omnipaque, Nycorned, Oslo, 
Norway). On day 7 another angiogram was made. A 
laparotomy was then performed and renal blood flow 
was measured by the ultrasonic flowmeter. In the 
Palmaz-group, the blood pressure in the suprarenal 
aorta and the renal arteries were also compared. 
Morphology 
The aortic segment containing the stent was fixed 
together with the kidneys under physiological pres- 
sure by instillation of 2.5 % glutaraldehyde solution. 
The fixed specimen was excised. The renal arteries 
were cut off close to the aortic wall in order to expose 
the metallic stent wire and its relation to the arterial 
orifice (Fig. 2). The aorta was longitudinally cut open 
to observe the impressions the stents had left in the 
aortic wall. Again, the relation to the renal arteries was 
noted (Fig. 3). The stent area was carefully searched 
for thrombus formation. The kidneys were examined 
by two pathologists. Each kidney was cut into thin 
slices to identify macroscopic signs of local infarction. 
Multiple sections from different parts of each kidney 
then underwent light microscopic examination in 
search of local ischaemia nd thrombosis or platelet 
deposition particularly in the glomerular 
capillaries. 24,25 
Statistical tests were performed applying Winstat 
software by Kalmia Co Inc. The values were expressed 
as median and interquartile range (I.Q.R.). Wilcoxon 
signed rank test was used for paired data. U-test 
(Mann Whitney) was used for group comparisons. 
p < 0.05 was considered significant. 
The study had been approved by the Animal Ethics 
Committee of Lund University and the animals were 
cared for according to the European Convention for 
Laboratory Animal Care. 
Fig. 1. Specimen ofpig aorta. A longitudinal aortotomy exposes the 
gianturco stent protruding above the dacron graft. The free part of 
the stent has been anchored atthe level of the renal arteries (R). In 
this case the left renal artery has been accidentally covered by both 
stent and graft. Minor thrombotic depositions are seen on the stent 
wires. 
Results 
It was usually feasible to place the endovascular ortic 
graft immediately below the renal arteries with such a 
precision that the proximal graft-anchoring stent 
covered the renal arteries while the graft did not. 
However, in pigs, the right and left renal arteries often 
originate from different levels which explains why six 
of the total 46 renal arteries involved were either 
uncovered by the stent (n = 4) or covered by both stent 
and graft (n = 2) and therefore had to be excluded from 
further analysis. Investigation of the specimens 
showed that a stent wire actually crossed the renal 
artery orifice in all but one of the successfully stent 
covered renal arteries. The median introperative blood 
flow in the renal arteries before stent deployment 
(n = 10) was 148 ml/min which corresponded to20 % 
(I.Q.R. 18 - 30 %) of the infrarenal aortic blood flow. 
Eur J Vasc Endovasc Surg Vol 13, February 1997 
210 M. Malina et al. 
Fig. 2. The aortic specimen has been cut to make the stent ends visible (S). The renal artery has been resected close to the aortic wall exposing 
not only the stent wire crossing it  orifice (O) but also any potential thrombus that may have been located in this region. 
Graft-stent study with 1 h follow-up 
One Gianturco stent covered renal artery occluded. 
The remaining arteries that had been successfully 
covered by stents all stayed patent (Fig. 4) and the 
median flow after i h was 14 % of aortic flow (I.Q.R. 7 
- 22 %), which was not significantly different com- 
pared to before stent deployment (p = 0.3). On angiog- 
raphy, in one animal, both renal arteries covered by a 
Palmaz stent had a lumen reduction with a mean 
blood pressure gradient between the suprarenal aorta 
and the involved renal artery of 6 and 12 mmHg 
respectively. All other renal arteries were morpho- 
logically normal. 
median T-MAX of 692 s (I.Q.R. 405 - 795 s) before stent 
placement and 675 s (535 - 785 s) on day 7. The 
median INCL was 6.6 counts/s (I.Q.R. 5.3 - 7.7 
counts/s) before intervention, and 9.0 counts/s (6.1 - 
9.5 counts/s) on dayT. None of these differences were 
statistically significant. The iohexol-clearance r plac- 
ing the renograms in the Palmaz group was 67 ml /  
min (I.Q.R. 60 - 74 ml/min)  before stent deposition 
and 70 ml /min  (I.Q.R. 66 - 75 ml/min)  after 1 week 
(N.S.). The median blood pressure gradient between 
the suprarenal aorta and the Palmaz stent covered 
renal arteries was 5.4 mmHg (I.Q.R. -0.9 - 6.8 
mmHg). 
Morphology 
Stent study with 1 week follow-up 
Renal blood flow at one week was 23 % of the 
infrarenal aortic blood flow (I.Q.R. 21 - 28 %), 23 % in 
the Palmaz and 24 % in the Gianturco groups. This 
was not significantly different from the flow of 20 % in 
the aforementioned un-stented arteries (p = 0.32). The 
final angiograms revealed no lumen discrepancies. 
The median creatinine level before stent deposition 
was 80.4 /xmol/1 (I.Q.R. 80 - 88 /xmol/1) and it 
remained at 76/xmol/1 (72 - 89/~mol/1) 7 days after 
the stents had been placed (N.S.). There was no 
difference between the Gianturco and Palmaz stents. 
The renograms in the Gianturco group showed a 
In the 1 week follow-up series, no macroscopic 
thrombotic depositions could be noted on the stent or 
adjacent vessel wall. In the graft-stent series, minor 
thrombotic depositions on both graft and stent were 
seen in all cases after I h. No signs of focal infarctions 
were noted on macroscopic examination of the kid- 
neys. Light microscopy revealed no signs of local 
ischaemia or capillary obstruction by thrombus or 
platelet depositions. 
Discussion 
Endovascular exclusion of abdominal aortic aneu- 
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rysms with grafts anchored by stents has been shown 
to be feasible in several series. ~3-17 A number of 
different endovascular graft deployment systems are 
under development and evaluation. Although these 
new techniques are less extensive procedures than a 
conventional operation, complications have been 
reported. For example in the series by Parodi et al., 14 a 
number of cases had leakage around the graft and in 
two cases microembolisation ccurred. Fear of occlud- 
ing a renal artery may lead to a suboptimal placement 
of the proximal stent resulting in proximal eakage or 
stent displacement, is A major limitation for endovas- 
cular grafting is that for proper anchoring of the graft 
a 15 - 20 mm long infrarenal neck is required. Because 
of this, some 30 - 40 % of aneurysms are unsuitable for 
endovascular repair by the present echnique. 26 If the 
anchoring stents could be placed above the orifices of 
the renal arteries, a larger proportion of patients with 
abdominal aortic aneurysms could be treated by the 
endovascular technique. Also, it would enable usage 
of longer stents optimising the attachment tothe aortic 
wall. 
In this experimental model it was technically 
feasible in most cases to attach the aortic graft 
immediately below the renal arteries with such an 
accuracy that the renal arteries were covered by the 
graff-anchoring stent only. The two cases where a 
renal artery was accidentally covered by stent and 
graft and consequently occluded, illustrate the haz- 
ards of intentionally placing stentgrafts in the vicinity 
of the renal arteries. Since the Gianturco stents 
consisted of 12 longitudinally arranged wires and the 
circumference of vessels with the diameter of 12 mm 
was 38 mm, there was a longitudinally running wire 
Fig. 3. The aortic specimen has been opened longitudinally and the 
stent removed. The longitudinal impressions in the intima fter the 
stent wires are clearly visible. So is their relation to the renal arterial 
orifice (O). 
Fig. 4. An intraoperative angiogram where the arrows point at the 
proximal and distal ends of the two graft anchoring Gianturco 
stents (S). The dacron graft is situated between them and is patent. 
The renal arteries (*) are both covered by the upper end of the 
proximal stent and remain patent. 
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every 3 mm. Under those circumstances, the probabil- 
ity that a renal artery may have stayed uncovered by 
a stent wire was small which also applied to the 
Palmaz stent where the pore diameter was smaller. 
The present study confirmed that all but one renal 
artery orifices were indeed crossed by a stent wire. 
The one occlusion seen in this series occurred in an 
artery covered by a Gianturco stent anchoring a graft 
that was of a slightly too wide diameter. Conse- 
quentlN this graft was not ideally expanded and we 
assume that the renal artery occlusion was caused by 
the thrombogenicity of the graft rather than by the 
stent itself. For this purpose, the second part of the 
experiment was designed involving stents only. The 
diameter of the human aorta is wider with higher flow 
rates, why it may be expected that graft thromboge- 
nicity will not cause renal artery occlusion in 
humans. 
The stent material has a fairly high thromboge- 
nicity, 27 but Palmaz et al. 5 reported that a combination 
of dextran and heparin reduced the clot formation, 
and that addition of aspirin and dipyridamole had the 
best antithrombotic effect. In our study we used 
heparin and dextran but some thrombotic depositions 
were noted after 1 h on the stents in the graft-stent 
study (Fig. 1). However, no macroscopic thrombotic 
material was seen on the stent wires after i week (Fig. 
2). Any such deposition would have been revealed by 
the approach including vital fixation and careful 
observation of the aortic lumen through the renal 
ostium. Vital fixation preserves thrombus while 
removing blood, thus facilitating the distinction 
between thrombus and postmortal clot. There was a 
possibility that minor thrombi could have been 
formed and embolised peripherally but this seems less 
probable as renal function, measured as creatinine 
level, radioactive uptake and iohexol clearance, was 
not affected within 1 week. Furthermore, on histo- 
logical examination there were no signs of micro- 
emboli n the kidneys which is usually readily seen on 
light microscopy both as depositions in the capillaries 
and as focal areas of ischaemia. Thus, this study could 
not reveal any differences in thrombogenicity between 
the stent types although their mechanical properties 
were different and although the metallic surface 
exposed to the blood stream was substantially larger 
in the Palmaz stents. 
In our study, during the 1 week follow-up part, 
renal blood flow, renograms and creatinine Values 
were unchanged. An unchanged GFR after i week has 
been reported. 2s The angiograms at 1 week did not 
show any lumen reduction in the renal arteries. 
However, at the initial placement, slight lumen reduc- 
tions were noted in one case. This could be due to 
spasm, a phenomenon that is seen after manipulation 
of vessels, as exemplified by angioplasty of the 
suprarenal aorta in rabbits which may lead to spasm 
of the renal arteries. 29 The fact that no lumen reduc- 
tions were seen after 1 week, supports this 
hypothesis. 
The results of animal experiments can never be 
directly applied to humans. Before adopting a new 
technique for humans additional basic testing in 
animals must be done. Further studies on the patency 
of accidentally stent covered collaterals in humans are 
also needed. It is highly desirable to investigate 
whether intimal hyperplasia will influence stent cov- 
ered sidebranches. The present short term study 
demonstrates that thrombogenicity b  itself does not 
influence their patency in this animal model. If it 
proves possible to place aortic stents over the orifices 
of renal arteries afely, it would be possible to treat a 
larger proportion of patients with abdominal aortic 
aneurysms by the endovascular technique. 
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